Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Cross-reactivity Study to Evaluate the Specificity of a Blood Test for Colorectal Cancer Diagnosis Based on Molecular Markers and Risk Factors Identified With Artificial Intelligence Tools

NCT06889844 is registered in ClinicalTrials.gov with ADVANCED MARKER DISCOVERY S.L. as lead sponsor.

NCT NCT06889844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06889844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Cross-reactivity Study to Evaluate the Specificity of a Blood Test for Colorectal Cancer Diagnosis Based on Molecular Markers and Risk Factors Identified With Artificial Intelligence Tools
Lead sponsor
ADVANCED MARKER DISCOVERY S.L.
Phase
Observational
Overall status
Recruiting
Start date
April 17, 2023
Completion date
December 31, 2025
Enrollment
250 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer